2. Objectives
• The Pelvic Exam and Vaginal Discharge
– Indications and Technique
• Gynecologic Abdominal Pain
– Acute vs Chronic
• Dysfunctional Uterine Bleeding
– Causes, Eval, and Treatment
• Amenorrhea/Dysmenorrhea
– Primary vs Secondary Amenorrhea
– Causes of Dysmenorrhea
• PCOS
• **This Material Represents ~ 4% of the material on the
Boards**
4. The Pelvic exam
• Valuable (and necessary) for many reasons
• Begin with the Basics!!!
– Vitals, Height, Weight, and Symptoms!!
• Provide explanation of the procedure and devices early
in the visit
– Sometimes helps to have a diagram of the female anatomy
handy
• Give the adolescent a choice of who can stay in the
room
• Position is key for an adequate exam
• Your goal is to complete a exam tailored to the
complaint and provide comfort to the patient
6. Indications for Exam
• Cervical Cancer Screening
• STI Testing and evaluation
• Pregnancy or postpartum
• Pain
• Discharge
• Itching
• Swelling
• Bleeding
• Menstrual Abnormalities
• Less common (Trauma, abnormalities of development)
7. What to look for
• Presence/absence of pubic hair
• Clitoral size
– Premenarchal is 3mm
• Configuration of the Hymen
• Signs of Estrogenization
– Moist, thick, and dull pink
• Hygiene
• Abnormalities from Normal
– Discharge
– Discoloration
– Trauma
– Anatomical Defects
8. Vaginal Discharge
• Can be physiologic or Inflammatory Leukorrhea
– Physiologic tends to be more clear/slightly yellow and
creamy in consistency 2
– Begins at onset of puberty and ends after menopause,
due to estrogen influence
• Often, color and consistency are clues to
diagnosis
• Important to be able to distinguish which
discharge needs which treatment
9. Adapted from Zitelli Atlas of Pediatric Diagnosis
Physiologic Candida Chlamydia Gonorrhea Trichomonas Bacterial
Vaginosis
HSV
Appearance White/Gray/Cle
ar/ Mucoid
White,
curdlike,
plaques
Mucopus at
cervix,
clear/bloody
discharge
Yellow/greenis
h discharge
Gray/yellow/gr
een,
malodorous,
frothy
Gray/white/
homogenous,
thin
Serous
Vaginal
Irritation
None, typically yes Not usual Not usual yes rare yes
pH <4.5 <4.5 variable <4.5 >4.5 >4.5 <4.5
Micro Epithelial cells,
lactobacilli, few
WBC
WBC’s,
pseudohyp-
hae with
budding yeast
Increased
WBC
Greatly
increased WBC
Greatly
increased WBC,
motile
trichomonads
Few WBC, but
clue cells
present
Greatly
increased
WBC
Clinical
Symptoms
none Itching,
dysuria,dy-
spareunia
Urethritis, PID,
perihepatitis
Urethritis, PID,
systemic
illness, proctitis
Vulvar itching,
prominent
dysuria, pelvic
discomfort
Fish-like odor LAN, pain
10. Vaginal Discharge: Treatments
• Candida:
– Fluconazole 150mg po x 1
• Chlamydia:
– Azithromycin 1g po x1
– Doxycycline 100mg po BID x 7d
– Levofloxacin 500mg po qd x 7d
• Gonorrhea:
– Ceftriaxone 250mg IM x1 plus Azithromycin 1g po x1 or Doxycycline 100mg
po BID x 7 days
• Trichomonas:
– Metronidazole/Tinidazole 2g po x1
– Metronidazole 500mg po BID x 7d
• Bacterial Vaginosis:
– Resolves spontaneously in up to 1/3 non-preg/ ½ preg women
– Metronidazole 500mg po BID x 7d
– Topical Clindamycin Cream (5g cream of 100mg Clinda) qhs x 7d
– Clindamycin 300mg po BID x 7d
11.
12. Gynecologic abdominal (Pelvic) pain
• Response to many conditions within the body
– Distension, stretching, compression, irritation, ischemia,
neuritis, necrosis
• Best classified/discussed as Acute vs Chronic causes
• In pre-pubertal girls, most often involves the GI or
Urinary tracts
– Gynecologic causes more likely in late adolescence
• Adolescent female with abdominal/pelvic pain
warrants a full evaluation and external genital exam,
often including a pelvic exam
– Indicated for sexually active females
13.
14. Ovarian Cyst
• Very common between
menarche and 18yo
– Mature follicles that fail to
ovulate (follicular) or involute
(CL)
• Classified as functional vs
Non-functional
– Functional = part of the
menstrual cycle
• Most asymptomatic and
found incidentally
– Could cause mentrual irreg.,
pain, urinary frequency,
constipation, or pelvic
heaviness
15. Ovarian Cyst Evaluation and
Management
• Evaluation
– Detailed menstrual and
sexual history
• Dysmenorrhea? OCP’s?
– UPT +/- CBC (ie, worried
about bleeding)
– Ultrasound
• Calcification = think
teratoma
• Management
– Follicular
• Usually resolve in 1-2
months
• <6cm = observe +/- OCP
• >6cm = observe vs
cystectomy (not
aspiration!)
– Corpus Luteum
• Observe 2wks-3mos (1st
Line) +/- OCP
• Persistent = cystectomy
16. Ovarian and Adnexal Torsion
• Ovarian torision =
complete/partial rotation of
ovary on its ligamentous
supports
– Adnexal when fallopian tube
also twisted
• Many causes
– Spontaneous common in
premenarchal girls
– Ovarian cyst or tumor
– Strenuous exercise
– Sudden increase abdominal
pressure
• MEDICAL EMERGENCY
17. Evaluation and Management of
Torsion
• Clinical
Presentation/Eval
– Typical is ACUTE onset of
mod/severe pelvic pain
with nausea +/- vomiting
with an adnexal mass
– Fever and bleeding
sometimes present
– Serum Hcg, CBC, and
BMP
– Ultrasound is 1st line DI
• Management
– Immediate surgical
intervention
• Necrosis possible after
~36 hours
• Now prefer to save rather
than remove the ovary
– Can reoccur
• High dose OCP’s can help
suppress cyst formation
• Oophoropexy done in
children without evidence
of mass
18. Ectopic Pregnancy
• Developing blastocyst implants somewhere other
than the uterus
• Incidence ranges from 6-16% and has increased
and plateaued since the mid-20th century
• 876 maternal deaths associated with ectopic
pregnancy between 1980 and 2007
• Sites of occurrence vary
– Almost all occur in the fallopian tube (~98%, most in
the ampullary)
– Other sites include: Cervix, Ovary,
Abdominal
19. Risk Factors for Ectopic Pregnancy
Low Moderate High
Previous
pelvic/abdominal
surgery
Infertility Previous ectopic
pregnancy
Vaginal douching Previous Cervicitis
(GC, Chlam)
Previous tubal
surgery
Early age of
intercourse (<18yo)
History of PID Tubal ligation
Multiple Sex
Partners
Tubal pathology
Smoking In utero DES
exposure
Current IUD use
20. Clinical Presentation
• Most common: 1st trimester vaginal bleeding and/or
abdominal pain
– Usually 6-8 weeks after LMP
– Bleeding quality and quantity varies
– Abdominal pain usually pelvic, but quality and timing can vary
• May be ruptured or unruptured at time of presentation,
and may even be asymptomatic
• Must be considered in all women of reproductive age who
present with vaginal bleeding and/or abdominal pain and:
– Are pregnant but IUP not confirmed
– Have unknown pregnancy status but amenorrhea >4 weeks
prior to episode
– Present with HD instability and an acute abdomen
21. Evaluation
• Obtain complete history and preform complete physical
– Detailed medical/menstrual history, sexual history, and past surgical
history
– Complete pelvic exam with bi-manual
• Confirm pregnancy
– Serum quantitative HcG level: measured serially every 48-72 hours,
usual doubling time is 1-2 days
– HcG that does not rise appropriately can be indicative of an
ectopic/abnormal pregnancy
– Transvaginal ultrasound (TVUS)
• Determine location of pregnancy
– TVUS
• Further assess stability of patient and consult with appropriate
specialists
22. Management
• If left untreated, could
progress to tubal abortion,
tubal rupture, or
spontaneous regression
• Conservative (hCG <5000,
HD stable, willing to follow
up, no fetal cardiac activity)
– Methotrexate IV, IM, or orally
– Single vs multidose protocols
(90% resolution for both)
• Surgical (ie HD unstable, CI
to MTX, etc)
– Salpingostomy vs
Salpingectomy
23. Chronic Pelvic Pain
• Usually defined as 3-6 months of pain
• Prevalence as high as 3.8% in women 15-73yo
• For adolescents, can potentially lead to missed school
days and inability to participate in social interactions
• Investigation into non-gynecologic organ systems very
important
• Often proceeds to laparoscopic investigation and
interventions
• Key Point!!!!
– Offer support and empathy, be non-judgmental, and most
of all be THOROUGH!!!
24. Age related incidence of laparoscopic findings in 129 adolescent patients with
chronic pelvic pain (Children’s Hospital Boston, 1980-1983)
Number of patients (%)
Diagnosis Age 11-13 Age 14-15 Age 16-17 Age 18-19 Age 20-21
Endometriosi
s
2 (12) 9 (28) 21 (40) 17 (45) 7 (54)
Postop
Adhesions
1 (6) 4 (13) 7 (13) 5 (13) 2 (15)
Serositis 5 (29) 4 (13) 0 (0) 2 (5) 0 (0)
Ovarian Cyst 2 (12) 2 (6) 3 (5) 2 (5) 0 (0)
Uterine
Malformatio
n
1 (6) 0 (0) 1 (2) 0 (0) 1 (8)
Other 0 (0) 1 (3) 2 (4) 1 (3) 0 (0)
No Path
Found
6 (35) 12 (37) 19 (36) 11 (29) 3 (23)
Reproduced from Pediatric and Adolescent Gynecology 5th Edition, Emans et al
25. Endometriosis
• Endometrial tissue located at sites outside the uterus
– Often discovered incidentally
• Chronic estrogen-dependent disorder, potentially
debilitating symptoms
– Pelvic pain, dysmenorrhea, dyspareunia, infertility
• Occurs in women of reproductive age (25-25 often)
– Rare in pre-pubertal and post-menopausal girls and women
• Negative risk factors and protective factors exist
– Negative: Nulliparity, early menarche/late menopause, short
cycles, prolonged menses, mullerian anormalities
– Protective: Multiple births, extended intervals of lactation, late
menarche
26. Endometriosis: Clinical Presentation
• Classic symptoms are
Dysmenorrhea (79%), Pelvic pain
(69%), dyspareunia (45%), and/or
infertility (26%)
• Pain is typically chronic, dull,
crampy, and occuring 1-2 days
prior to menses, then through
menses
• Can occur in the urinary or lower
GI tract, leading to bladder/bowel
symptoms as well
• ~1/4 of women will present as
infertility, 20% as an ovarian
mass, or again found completely
incidentially.
27. Endometriosis: Diagnosis
• History and PE
– Often no abnormal
findings, but pelvic
indicated
– Tenderness in posterior
vaginal fornix
• Labs
– None useful
• Diagnostics
– Pelvic US
• Surgery
– Laparoscopy (visual or
histologic diagnosis)
29. Abnormal Uterine Bleeding
• Bleeding that is excessive or occurs outside the normal cyclic
menstruation
• Most common cause during initial ~2 years of menstruation is anovulatory
cycles
• Specific definitions exist
– Duration >8 days
– Flow >80ml/cycle (or subjective impression of heavy flow)
– Occur >every 24 days or <every 38 days
– Intermenstrual bleeding/postcoital spotting
– Absence of menses
• Terminology
– Amenorrhea
– Irregular bleeding
– Heavy menstrual bleeding
– Acute bleeding
32. AUB: Evaluation
• ALWAYS start with the history and PE
– History with and without parent; detailed menstrual history with focus
on symptoms, medical history, medicines, FH, and social factors
– External Genital and Pelvic exam, in addition to tanner staging general
PE parameters
• Pelvic Ultrasound
– Indicated if PE limited or to evaluate internal structures
(present/absent)
• Laboratory evaluation
– UPT
– CBC
– TSH
– Other: Prolactin, type and cross
33. AUB: Treatment
• Observation and reassurance (mild)
• OCP’s
– Combination or Progestin Only
– Can be taken as much as TID x 48 hours if moderate-severe bleeding
• Iron Supplements
– Often can lead to iron deficiency
• Hemostatic Agents
– Desmopressin and Amicar
• Surgery
– D&C
• Hospitalization
– Hgb<10 + Heavy Bleeding, Initial Hgb <7, or Orthostatic Hypotension
34. Amenorrhea
• Absence of Menses
• Primary vs Secondary
– Primary amenorrhea defined
as the lack of menses by age
15 or 2 years after sexual
maturation has occurred
– If no sexual characteristics by
age 13, then begin workup
– Short Stature + Amenorrhea
(primary or secondary) =
THINK TURNER SYNDROME
37. Amenorrhea Treatment
Primary
• Education/Counseling
• Cause Specific
– Anatomic Lesion/Y
chromosome Material =
Surgery
– Primary OF = HRT
– PCOS = TBA/Goal Oriented
– Hypothalamic Amenorrhea =
weight gain, stress/exercise
modification, GnRH (help
infertility issues)
Secondary
• Directed at the underlying
pathology
• Hypothalamic
– Lifestyle Change
– CBT
– Leptin Administration (experimental)
• Hyperprolactinemia
– Depends on cause and goals
• Premature OF
– Estrogen therapy (OCP or HRT)
• PCOS
– TBA/Goal Oriented
• Asherman Syndrome
– Hysteroscopic lysis of adhesions, long
term estrogen therapy
38. Dysmenorrhea
• Recurrent, crampy lower abdominal pain during menstruation
– Responsible for episodic school absence in girls/young women
– Prevalence 60-93% in adolescent females, only 15% seek medical
advice
– Does not occur until menstrual cycles are established
• Primary vs Secondary
– Primary = no obvious organic disease
– Secondary = IUD, PID, Endometriosis, other organic disease
• Pathophysiology
– Believed to be caused by excess production of endometrial
prostaglandin F2 alpha
– Leads to dysrhythmic uterine contractions and increased muscle tone
uterine ischemia
– Also see nausea, vomiting, and diarrhea due to GI tract stimulation
39. Dysmenorrhea
• Clinical Symptoms
– Abdominal Pain (lower quadrant) several hours prior to
menses, lasting for several days
– Nausea, Vomiting, Diarrhea, HA, dizziness, or back pain
– Can impact daily activities
• Treatment
– 1st line: NSAID’s
• Ibuprofen, Naproxen
– 2nd line: Birth Control (can combine with NSAID’s)
– Exercise, APAP, healthy diet, and rest are overly ineffective
40. What’s in a name?
• Pre-Menstrual Syndrome
– The occurrence of at least one affective (emotional
labiality, depression) or physical (breast pain, bloating)
symptom associated with economic or social dysfunction
during the 5 days preceding a menstrual cycle and present
in at least 3 cycles
• Pre-Menstrual Dysphoric Syndrome
– Symptoms present for most of the preceding year, and 5 or
more of the symptoms being present during the week
prior to menses and resolving shortly after menses
• Must have significant distress or impairment of daily activities
41. PMDD: A Psychiatric Diagnosis
1+ must be present
• Mood swings, sudden
sadness, increased
sensitivity to rejection
• Anger, irritability
• Sense of hopelessness,
depressed mood, self-
critical thoughts
• Tension, anxiety, feeling on
edge
1+ must be present to reach total
of 5 symptoms
• Difficulty concentrating
• Change in appetite, food cravings,
overeating
• Diminished interest in usual
activities
• Easy fatigability, decreased
energy
• Feeling overwhelmed, or out of
control
• Breast tenderness, bloating,
weight gain, or joint/muscles
aches
• Sleeping too much or not
sleeping enough
42. Polycystic Ovarian Syndrome
• Disorder of the H-P-O
System
temporary/persistent
anovulation and
androgen excess
• Requires 2/3 Criterion
(2003 Rotterdam
Consensus)
– Oligo and/or anovulation
– Clinical and/or biochemical
signs of hyperandrogenism
– Polycystic Ovaries by US
43. PCOS
• Very common cause of amenorrhea (Primary and Secondary)
• Most common cause of hyperandrogenism in women and girls
– Affects 5-10% of premenopausal girls
• Close association with diabetes
– Insulin resistance increased metabolic and cardiovascular risks
• Pathophysiology is unclear
– Abnormal H-P function
– Abnormal Ovarian function
– Abnormal adrenal androgen metabolism
– Insulin resistance hyper insulinemic state excessive ovarian
androgen production by theca cells
46. Take Home Messages
• Don’t be afraid of the
pelvic exam
• More information is
better than no
information for our
patients
• Consider pregnancy in
any reproductive age
female with abdominal
pain or odd presenting
symptoms
• Do not underestimate the
social or psychological
impairments of
gynecologic disease
Editor's Notes
-Just as a reminder. Avg menstruation is 28-35 days
-Most variability present in the first 5-7 years after menarche and the last 10 years of menstruation
-Cycle length peaks at age 25-30
-Reasons Valuable: External exam to focus on dysmorphic changes, external infections (folliculitis, vulvar candidiasis, vulvar dermatoses), internal exam can yield several diagnostic studies (pap smears, STI testing) as well as visual clues (strawberry cervix with trich, discharge, cancers/warts)
-A: Fimbriated Hymen; B: Posterior Rim/Crescentic Hymen; C: Circumferential/Annular Hymen
-Remember, 80-95% of girls who are victims of sexual abuse have a normal external genital exam
-Candida: 10-20% who harbor candida are asymptomatic. Fluconazole maintains therapeutic concentrations for 72 hours. Complicated infections, 150mg po q72h x 3 doses
C. glabrata fails with azoles commonly (use flucytosine cream). C. krusei resistant to fluconazole, use clotrimazole cream/suppose
-no general rec for treating partners
-Gonorrhea: New guidelines in 2012 represent growing emergence of cephalosporin resistance patterns in GC.
-Trich: allergy to flagyl = recommend desensitization; same treatment for male partners
BV: treat if symptomatic, may also reduce the risk of acquiring other STD’s
Tinidazole has a longer half life and fewer side effects, therefore it is an alternative, 1g po x 5days
-Ruptured cyst can lead to minor or severe bleeding
Functional Cysts: Follicular cysts, Corpus Luteum Cysts, Thecal Cysts
Non-Functional Cysts: Ovary with many cysts (PCOS), Chocolate Cysts (Endometriosis), Hemorrhagic Ovarian Cyst, Dermoid Cysts, Ovarian serous cystadenoma, Ovarian Mucinous Cystadenoma, Paraovarian cyst, Cystic Adenofibroma, Borderline Tumoral Cysts
Right ovary more common to twist than left (? Ligament longer, and left supported by sigmoid colon)
Ligaments involved: infundibulopelvic ligament (fold of the broad ligament, holds vessels), utero-ovarian ligament, broad ligament
-Previous ectopic pregnancy (conservative treatment) carries risk as high as 15%!
-In-utero DES expoure increases the rates of abnormal tubal morphology
-Hormonal contraception can be protective (ironically, IUD use is included in this, but if conception occurs, the risk of ectopic pregnancy is high)
PE findings: abdominal exam range from unremarkable to exquisite tenderness, uterus may be slightly enlarged, and cervical motion/adnexal tenderness may/may not be present. May see HD variations or instability
Other tests: CBC, blood type and screen, CMP (if going to be treated with methotrexate); may need to give Rhogam if Rh (d) negative
-In one study, was seen in 50% of teenagers undergoing laproscopy for evaluation of chronic pain or dysmenorrhea
-Anatomic abnormalities may lead to retrograde menstruation, which could potentially increase the risk of endometriosis, also a familial tendency has been identified as well (as high as 7% in 1st degree relatives).
-Primary Dysmenorrhea tends to occur with menarche; dysmenorrhea with endometriosis often is after menarche.
-Often, there is therapeutic intervention at the time of diagnosis (during laparoscopy); helps to prevent/delay disease progression and avoid expense/SE of medical therapy
-OCP’s vs GnRH agonists both equal for pain relief
-GnRH agonists and Danazol induce “pseudomenopause; progestins alone mimic pregnancy (inhibit endometrial tissue growth and also inhibit pituitary gonadotropin secretion, ovarian hormone production)
-Danazol has progestin-like effects, and helps to inhibit the growth and resolve implants (SE weight gain, muscle cramps, acne, hirsutism)
-Aromatase inhibitors prevent estrogen production
-Annovulation is due to a immature hypothalamic-pituitary axis.
Dysfunctional Uterine Bleeding: excessive (> every 21 days) non-cyclic endometrial bleeding unrelated to anatomic lesions or systemic disease; Anovulatory uterine bleeding is another term for this, and is a diagnosis of exclusion
-Menometrohaggia: prolonged/excessive uterine bleeding that occurs irregulalrly or more frequently than normal (irregular menses with menorhhagia (causes include cancer, hormonal imbalance, progestin only contraception, endometriosis, and fibroids)
-Ovarian Failure, if the cause, can lead to osteoporosis
Medical History: Chronic medical illness
Medicines: use of OCP
FH: coagulation or gynecologic disorders
Social: Stressors, exercise, sexual activity
PE Pearls: Look for androgen excess, look at body distribution, palpate thyroid gland, look for evidence of brusing, general skin exam for possible acanthosis, examine abdomen for masses
Also, blood transfusion
-Hemostatic agents are commonly seen in use for VWD
Secondary amenorrhea: cessation of menses after menarche for 6 months/length of time equal to 3 previous cycles
-
-In eating disorders, amenorrhea may preceed the weight loss; menstrual irregularity not a diagnostic criterion for bulimia, and no longer for Anorexia
-Idiopathic Hypogonadotropic Hypogonadism + Anosmia = Kallman’s Syndrome
Secondary Amenorrhea:
-Drugs: Phenothiazines, OCP, Glucocorticoids, Heroin
-Endocrine: Hypo/Hyperthyroidism, cortisol excess
-Chronic Illness: Cystic Fibrosis, DM1
-Hypothalamic Failure: Idiopathic, Lesions (Cranipharyngioma)
-PCOS: ? Hypothalamic disorder according to researchers
Pituitary:
-Lesions: Sheehan Syndrome, empty sella syndrome, infiltration with hemochromatosis, Adenomas
Ovarian:
-Ovarian Failure: Menopause <35yo (autoantibodies)
-Ashermann Syndrome: Uterine Synechiae accompianed by symptoms of infertility or amenorrhea
-Pregnancy
Primary Amenorrhea:
-Look at secondary characteristics (Breast development, Uterus Present/Absent); if both present, then look for cyclic pain which could be due to vaginal outlet obstruction; if no cyclic pain, pursue your secondary amenorrhea workup.
-Serum Testosterone distinguishes between Testicular feminization (Male testosterone level, 46XY) and Congenital Absence of Uterus (Female test. Level, 46XX)
-If high blood pressure, look for 17-alpha-hydroxylase deficiency.
Hirsutism: Seen in 2/3 of hyperandrogenic females, diagnosed based on grading scale (Ferriman-Gallway System, score of 8 or more, varies based on ethnicity)
Hypertrichosis: Non-sexual/more generalized pattern, such as on forehead, shoulders
Acne: in PCOS, moderate or more inflammatory (>10 facial lesions), harder to treat with traditional measures
Balding: Male Pattern (fronto-temporal) or female pattern (Crown)
Other hyperandrogenism: Hidradenitis suppurativa, hyperhidrosis, seborrhea
Anovulation: Varied and often difficult to link with PCOS, chronic anovulation associated with endometrial hyperplasia and carcinoma
Obesity: present in 50% of those with PCOS, central obesity is waist circumference of >88cm in adolescent and adult females
Metabolic Syndrome: 25% have this, not well defined parameters in pediatrics, components are HyperTG, central obesity, hyperglycemia, low HDL, and HTN
SDB: longer sleep latency, poorer sleep efficiency, and lower percentage of REM sleep
NASH: Association with insulin resistance and dyslipidemia
-Cyclic progestin do not effectively help hirsutism (Avoid estrogen effects of thromboembolism [4X increased risk in 1st time users] and linear growth inhibition in perimenarchal girls with open growth plates)
-Suspect adrenal hyperandrogenism if the levels of testosterone do not normalize with OCP administration
-Metformin often used with or without evidence of glucose intolerance
-Aldactone lowers hirsutism by 1/3